Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 303

The DOI matches its Crossref record; 75 of the 75 references it cites were found in a registry or an index.

Essential Gene Profiles in Breast, Pancreatic, and Ovarian Cancer Cells

Open access
Marcotte, Richard, Brown, Kevin R., Suarez, Fernando, Sayad, Azin, Karamboulas, Konstantina, Krzyzanowski, Paul M., Sircoulomb, Fabrice, Medrano, Mauricio, Fedyshyn, Yaroslav, Koh, Judice L.Y., van Dyk, Dewald, Fedyshyn, Bohdana, Luhova, Marianna, Brito, Glauber C., Vizeacoumar, Franco J., Vizeacoumar, Frederick S., Datti, Alessandro, Kasimer, Dahlia, Buzina, Alla, Mero, Patricia, Misquitta, Christine, Normand, Josee, Haider, Maliha, Ketela, Troy, Wrana, Jeffrey L., Rottapel, Robert, Neel, Benjamin G., Moffat, Jason·2012·Cancer Discovery

Abstract

Genomic analyses are yielding a host of new information on the multiple genetic abnormalities associated with specific types of cancer. A comprehensive description of cancer-associated genetic abnormalities can improve our ability to classify tumors into clinically relevant subgroups and, on occasion, identify mutant genes that drive the cancer phenotype (“drivers”). More often, though, the functional significance of cancer-associated mutations is difficult to discern. Genome-wide pooled short hairpin RNA (shRNA) screens enable global identification of the genes essential for cancer cell survival and proliferation, providing a “functional genomic” map of human cancer to complement genomic studies. Using a lentiviral shRNA library targeting ∼16,000 genes and a newly developed, dynamic scoring approach, we identified essential gene profiles in 72 breast, pancreatic, and ovarian cancer cell lines. Integrating our results with current and future genomic data should facilitate the systematic identification of drivers, unanticipated synthetic lethal relationships, and functional vulnerabilities of these tumor types. Significance: This study presents a resource of genome-scale, pooled shRNA screens for 72 breast, pancreatic, and ovarian cancer cell lines that will serve as a functional complement to genomics data, facilitate construction of essential gene profiles, help uncover synthetic lethal relationships, and identify uncharacterized genetic vulnerabilities in these tumor types. Cancer Discovery; 2(2); 172–89. © 2011 AACR. This article is highlighted in the In This Issue feature, p. 95.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1158/2159-8290.cd-11-0224

Cites

75 of 75 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

1 retracted

Show all 75 references

Cited by

See all 303

Metadata

Authors
Marcotte, R., Brown, K. R., Suarez, F., Sayad, A., Karamboulas, K., Krzyzanowski, P. M., Sircoulomb, F., Medrano, M., Fedyshyn, Y., Koh, J. L. Y., van Dyk, D., Fedyshyn, B., Luhova, M., Brito, G. C., Vizeacoumar, F. J., Vizeacoumar, F. S., Datti, A., Kasimer, D., Buzina, A., Mero, P., Misquitta, C., Normand, J., Haider, M., Ketela, T., Wrana, J. L., Rottapel, R., Neel, B. G., & Moffat, J.
Venue
Cancer Discovery
Published
2012-02-01
Volume
2
Issue
2
Pages
172-189
ISSN
  • 2159-8274 (ISSN-L)
  • 2159-8290
OpenAlex
W2099505694
Cited by
303
References
75
FWCI
5.40
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Essential Gene Profiles in Breast, Pancreatic, and Ovarian Cancer Cells. https://app.cochat.ai/papers/10.1158/2159-8290.cd-11-0224
The paper
Marcotte, R., Brown, K. R., Suarez, F., Sayad, A., Karamboulas, K., Krzyzanowski, P. M., Sircoulomb, F., Medrano, M., Fedyshyn, Y., Koh, J. L. Y., van Dyk, D., Fedyshyn, B., Luhova, M., Brito, G. C., Vizeacoumar, F. J., Vizeacoumar, F. S., Datti, A., Kasimer, D., Buzina, A., . . . Moffat, J. (2012). Essential Gene Profiles in Breast, Pancreatic, and Ovarian Cancer Cells. Cancer Discovery. https://doi.org/10.1158/2159-8290.cd-11-0224

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.